FDA PMA FDA Class 3 Approved 🇺🇸 United States

Microspheres Radionuclide

PMA: P990065 · Supplement: S010 · Decision Jan 18, 2017
Classifications
1
FEI Numbers
8
Registration Numbers
8

Basic Information

Device Name
Microspheres Radionuclide
Trade Name
SIR-SPHERES MICROSPHERES
PMA Number
P990065
Supplement Number
S010
Device Class
FDA Class 3
Product Code
NAW
Generic Name
Microspheres radionuclide
Medical Specialty
Unknown
Advisory Committee
Radiology
Decision
Approved
Decision Code
APPR
Decision Date
January 18, 2017
Date Received
December 19, 2016
Supplement Type
Special (Immediate Track)
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Approval for changes in device package insert with insertion of BSA model to replace the current empirical model for calculation of individual required activity dose, change of lung shunt fraction to total lung dose, less than 30 Gy to apply in the dose calculation, re-define the Radio-Embolization Induced Liver Disease (REILD) and addition of dose reduction guidance in REILD, addition of guidance of lobar therapy using BSA model, and deletion of empirical model and partition model for dose calculation.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NAW Microspheres Radionuclide